During this CPFF Educational Session, Dr. Shane Shapera, discusses the treatment of Scleroderma interstitial lung disease (SSc-ILD). At the end of this talk, listeners will be able to describe what Scleroderma interstitial lung disease means and better understand the risk factors for SSc-ILD development and its progression and the evidence for and against anti-inflammatory and anti-fibrotic treatment of SSc-ILD.
Dr. Shane Shapera is an Associate Professor and Clinician Educator in the Faculty of Medicine at the University of Toronto. He is currently the Director of the Interstitial Lung Diseases Program at the Toronto General Hospital which is part of the University Health Network. He also works with the Toronto Lung Transplant Program providing pre-lung transplant assessments for patients with interstitial lung disease.